Last updated: February 20, 2026
What is the drug associated with NDC 43598-0588?
The drug identified by NDC 43598-0588 is [Drug Name], marketed for [Indication]. It is a [formulation] drug with approval date [approval date]. The drug is manufactured by [Manufacturer].
Market Overview
The drug targets [patient population], primarily used in [therapeutic setting or disease]. The global market size for [indication] was valued at USD X billion in [year] and is expected to grow at a CAGR of X% through [year].
Key Competitors
| Brand Name |
Strengths |
Market Share |
Price (USD) |
Launch Date |
| [Competitor A] |
Established brand recognition |
X% |
$X,XXX |
[date] |
| [Competitor B] |
Broader distribution |
X% |
$X,XXX |
[date] |
| [Competitor C] |
Lower-cost alternative |
X% |
$X,XXX |
[date] |
Regulatory Status
- Approved by FDA: Yes/No (Date: [date])
- Pending patents: Yes/No, patents expire [year]
- Extended exclusivity: [Yes/No] (e.g., Orphan Drug designation, Patent Term Extensions)
Market Drivers and Barriers
Drivers:
- Increasing prevalence of [indication]
- Patent exclusivity providing a market monopoly
- Supportive reimbursement policies
Barriers:
- Patent expiry risks
- Pricing pressures from healthcare payers
- Competition from generics or biosimilars
Pricing Analysis
Current Pricing
| Region |
Wholesale Acquisition Cost (WAC) |
Average Selling Price (ASP) |
Out-of-Pocket Cost |
| US |
$X,XXX |
$X,XXX |
$X,XXX |
| EU |
€X,XXX |
€X,XXX |
€X,XXX |
Price Trends (Recent 2 Years)
Prices for [drug] have [increased/decreased/stabilized] due to factors such as [patent protections, market entry, pricing regulations].
Price Process Factors
- Patent expiry scheduled for [year]
- Entry of biosimilars or generics anticipated [year]
- Reimbursement changes impacting net prices
Projected Market Growth and Pricing
Revenue Projections
| Year |
Estimated Sales (USD millions) |
Market Share (%) |
Average Price (USD) |
Annual Growth Rate (%) |
| 2023 |
$X,XXX |
X% |
$X,XXX |
0% |
| 2024 |
$X,XXX |
X% |
$X,XXX |
+X% |
| 2025 |
$X,XXX |
X% |
$X,XXX |
+X% |
Price Forecasts
The price for [drug] is expected to [increase/decrease/stabilize] by X% over the next [timeframe] because of [market entry of generics, regulatory changes, manufacturer strategies]. Post-patent expiry (~[year]), generic competition could reduce prices by (X-XX)%.
Risks to Market and Price Projections
- Patent expiration leading to price erosion
- Introduction of biosimilar or generic competition
- Changes in healthcare policy or reimbursement frameworks
- Patent litigation delays or disputes
Key Takeaways
- The drug [name] holds a market share primarily driven by [drug’s efficacy, patent exclusivity, brand recognition].
- Prices have remained relatively [stable/volatile], subject to patent status and competitive pressures.
- Post-patent expiry, expected price declines of (X-XX)% within [time].
- Growth depends on [indication prevalence, regulatory landscape, competitive dynamics].
FAQs
-
When does patent expiry occur for NDC 43598-0588?
Patent expiration is projected for [year], after which generic competition is likely to increase.
-
Are biosimilars or generics available?
Currently, [yes/no]. If yes, they entered the market in [year] with prices approximately [X]% lower.
-
What are the primary factors influencing price changes?
Patent status, regulatory approvals, market competition, and reimbursement policies drive price trends.
-
What regions offer the highest market potential?
The US and [region] represent [percentage] of sales, with potential growth in [emerging markets].
-
What is the forecasted impact of upcoming patent expiries?
Expect a [X]% drop in average price within [timeframe] due to generic entry and increased competition.
References
[1] U.S. Food and Drug Administration. (2023). Approved drug products. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products
[2] IQVIA. (2022). Market analysis report for [indication] drugs.
[3] EvaluatePharma. (2023). Global pharmaceutical market forecast.
[4] U.S. Patent and Trademark Office. (2023). Patent status for [drug or manufacturer].
Disclaimer: Data points should be confirmed with the latest pharmaceutical market reports and patent databases.
